Современные подходы к ведению детей с острым бронхиолитом

Экспертами Союза педиатров России разработаны актуальные методические рекомендации по оказанию медицинской помощи детям с острым бронхиолитом. Ежегодно в мире регистрируется около 150 млн случаев бронхиолита (11 заболевших на 100 детей грудного возраста), 7–13 % из которых требуют стационарного лечения и 1–3 % — госпитализации в отделение интенсивной терапии. Респираторно-синцитиальную вирусную инфекцию переносят практически все дети в первые 2 года жизни (90 %), однако лишь приблизительно в 20 % случаев у них развивается бронхиолит, что обусловлено различными факторами. В статье подробно освещены вопросы эпидемиологии, патогенеза, дифференциальной диагностики, лечения, основанные на принципах доказательности.

1. Классификация клинических форм бронхолегочных заболеваний у детей. — М.: Российское респираторное общество, 2009. — 18 с. [Klassifikatsiya klinicheskikh form bronkholegochnykh zabolevaniy u detey. Moscow: Rossiyskoye respiratornoye obshchestvo; 2009. 18 р. (In Russ).]

2. Ralston SL, Lieberthal AS, Meissner HC, et al; American Academy of Pediatrics. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014;134(5):e1474– 1502. doi: 10.1542/peds.2014-2742.

3. Paediatric Respiratory Medicine ERS Handbook. 1st Edition. Ed. Eber E., Midulla F. European Respiratory Society; 2013. 719 р.

4. Miller EK, Bugna J, Libster R, et al. Human rhinoviruses in severe respiratory disease in very low birth weight infants. Pediatrics. 2012;129(1):e60–67. doi: 10.1542/peds.2011-0583.

5. Janssen R, Bont L, Siezen CL, et al. Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J Infect Dis. 2007;196(6):826–834. doi: 10.1086/520886.

6. Figueras-Aloy J, Carbonell-Estrany X, Quero J; IRIS Study Group. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain. Pediatr Infect Dis J. 2004;23(9):815–820. doi: 10.1097/01.inf.0000136869.21397.6b.

7. Law BJ, Langley JM, Allen U, et al. The Pediatric investigators collaborative network on infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J. 2004;23(9):806–814. doi: 10.1097/01.inf.0000137568.71589.bd.

8. Stensballe LG, Kristensen K, Simoes EA, et al.; Danish RSV Data Network. Atopic disposition, wheezing, and subsequent respiratory syncytial virus hospitalization in Danish children younger than 18 months: a nested case-control study. Pediatrics. 2006;118(5):e1360–1368. doi: 10.1542/peds.2006-0907.

9. Ralston S, Hill V, Waters A. Occult serious bacterial infection in infants younger than 60 to 90 days with bronchiolitis: A systematic review. Arch Pediatr Adolesc Med. 2011;165(10):951–956. doi: 10.1001/archpediatrics.2011.155.

10. Hall CB, Simőes EA, Anderson LJ. Clinical and epidemiologic features of respiratory syncytial virus. Curr Top Microbiol Immunol. 2013;372:39–57. doi: 10.1007/978-3-642-38919-1_2.

11. Thorburn K, Harigopal S, Reddy V, et al. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax. 2006;61(7):611–615. doi: 10.1136/thx.2005.048397.

12. Duttweiler L, Nadal D, Frey B. Pulmonary and systemic bacterial co-infections in severe RSV bronchiolitis. Arch Dis Child. 2004;89(12):1155. doi: 10.1136/adc.2004.049551.

13. Таточенко В.К. Болезни органов дыхания у детей: практическое руководство. Новое изд., доп. — М.: ПедиатрЪ, 2015. — 396 с.

14. Патрушева Ю.С., Бакрадзе М.Д. Этиология и факторы риска острого бронхиолита у детей // Вопросы диагностики в педиатрии. — 2012. — Т.4. — №3. — С. 45–52.

15. Патрушева Ю.С., Бакрадзе М.Д., Куличенко Т.В. Диагностика и лечение острого бронхиолита у детей // Вопросы диагностики в педиатрии. — 2011. — Т.3. — №1. — С. 5–11.

16. Doan QH, Kissoon N, Dobson S, et al. A randomized, controlled trial of the impact of early and rapid diagnosis of viral infections in children brought to an emergency department with febrile respiratory tract illnesses. J Pediatr. 2009;154(1):91–95. doi: 10.1016/j.jpeds.2008.07.043.

17. Doan Q, Enarson P, Kissoon N, et al. Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department. Cochrane Database Syst Rev. 2014;(9):CD006452. doi: 10.1002/14651858.CD006452.pub4.

18. 18. UpToDate is the only clinical decision support resource associated with improved outcomes [Internet]. UpToDate, 2019. Available from: https://www.uptodate.com/home.

19. Cordier JF, ed. Orphan Lung Diseases. Vol. 54. Chapter 5. Bronchiolitis. European Respiratory Society Monograph; 2011. Pр. 84–103.

20. Спичак Т.В. Постинфекционный облитерирующий бронхиолит у детей. — М. Научный мир, 2005. — 96 с.

21. Spurling GK, Doust J, Del Mar CB, Eriksson L. Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev. 2011;(6):CD005189. doi: 10.1002/14651858.CD005189.pub3.

22. Mazur NI, Martin n-Torres F, Baraldi E, et al.; Respiratory Syncytial Virus Network (ReSViNET). Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics. Lancet Respir Med. 2015;3(11):888–900. doi: 10.1016/S2213-2600(15)00255-6.

23. Оказание стационарной помощи детям. Руководство по лечению наиболее распространенных болезней у детей: карманный справочник. 2-е изд. — М.: ВОЗ, 2013. — 452 с.

24. Caffrey OE, Clarke JR. NICE clinical guideline: bronchiolitis in children. Arch Dis Child Educ Pract Ed. 2016;101(1):46–48. doi: 10.1136/archdischild-2015-309156.

25. Gadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2014;(6):CD001266. doi: 10.1002/14651858.CD001266.pub4.

26. Wu S, Baker C, Lang ME, et al. Nebulized hypertonic saline for bronchiolitis: a randomized clinical trial. JAMA Pediatr. 2014;168(7):657–663. doi: 10.1001/jamapediatrics.2014.301.

27. Chen YJ, Lee WL, Wang CM, Chou HH. Nebulized hypertonic saline treatment reduces both rate and duration of hospitalization for acute bronchiolitis in infants: an updated meta-analysis. Pediatr Neonatol. 2014;55(6):431–438. doi: 10.1016/j.pedneo.2013.09.013.

28. Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev. 2017;12:CD006458. doi: 10.1002/14651858.CD006458.pub4.

29. Fernandes RM, Bialy LM, Vandermeer B, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2013;(6):CD004878. doi: 10.1002/14651858.CD004878.pub4.

30. Fernandes RM, Bialy LM, Vandermeer B, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2013;(6):CD004878. doi: 10.1002/14651858. CD004878.pub4.

31. Roqué FM, Giné-Garriga M, Granados RC, et al. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev. 2016;2:CD004873. doi: 10.1002/14651858.CD004873.pub5.

32. Nishimura T, Suzue J, Kaji H. Breastfeeding reduces the severity of respiratory syncytial virus infection among young infants: a multicenter prospective study. Pediatr Int. 2009;51(6):812–816. doi: 10.1111/j.1442-200X.2009.02877.x.

33. Dornelles CT, Piva JP, Marostica PJ. Nutritional status, breastfeeding, and evolution of infants with acute viral bronchiolitis. J Health Popul Nutr. 2007;25(3):336–343.

34. Strachan DP, Cook DG. Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax. 1997;52(10):905–914. doi: 10.1136/thx.52.10.905.

35. Jones LL, Hashim A, McKeever T, et al. Parental and household smoking and the increased risk of bronchitis, bronchiolitis and other lower respiratory infections in infancy: systematic review and metaanalysis. Respir Res. 2011;12:5. doi: 10.1186/1465-9921-12-5.

36. Bradley JP, Bacharier LB, Bonfiglio J, et al. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics. 2005;115(1):e7–14. doi: 10.1542/peds.2004-0059.

37. Al-Shawwa B, Al-Huniti N, Weinberger M, Abu-Hasan M. Clinical and therapeutic variables influencing hospitalisation for bronchiolitis in a community-based paediatric group practice. Prim Care Respir J. 2007;16(2):93–97. doi: 10.3132/pcrj.2007.00018.

38. Hall CB. Nosocomial respiratory syncytial virus infections: the “Cold War” has not ended. Clin Infect Dis. 2000;31(2): 590–596. doi: 10.1086/313960.

39. Hall CB, Douglas RG Jr, Geiman JM. Possible transmission by fomites of respiratory syncytial virus. J Infect Dis. 1980;141(1):98– 102. doi: 10.1093/infdis/141.1.98.

40. Sattar SA, Springthorpe VS, Tetro J, et al. Hygienic hand antiseptics: should they not have activity and label claims against viruses? Am J Infect Control. 2002;30(6):355–372. doi: 10.1067/mic.2002.124532.

41. Picheansathian W. A systematic review on the effectiveness of alcohol-based solutions for hand hygiene. Int J Nurs Pract. 2004;10(1):3–9. doi: 10.1111/j.1440-172x.2003.00457.x.

42. American Academy of Pediatrics Committee on Infectious Diseases; American Academy of Pediatrics Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014;134(2):e620– 638. doi: 10.1542/peds.2014-1666.

43. Баранов А.А., Иванов Д.О., Алямовская Г.А., и др. Паливизумаб: четыре сезона в России // Вестник Российской академии медицинских наук. — 2014. — Т.69. — №7-8. — С. 54–68.doi: 10.15690/vramn.v69i78.1110.